TY - JOUR
T1 - TLR2 agonist prevents the progression of periapical lesions in mice by reducing osteoclast activity and regulating the frequency of Tregs
AU - Almeida, Lana Kei Yamamoto
AU - Battaglino, Ricardo Anibal
AU - Araujo, Lisa Danielly Curcino
AU - Lucisano, Marília Pacífico
AU - Massoni, Vivian Vicentin
AU - da Silva, Léa Assed Bezerra
AU - Nelson-Filho, Paulo
AU - Morse, Leslie Rae
AU - da Silva, Raquel Assed Bezerra
N1 - Publisher Copyright:
© 2024 British Endodontic Society. Published by John Wiley & Sons Ltd.
PY - 2024/3
Y1 - 2024/3
N2 - Aim: To evaluate the role of regulatory T lymphocytes (Tregs) in the presence or absence of the synthetic ligand Pam3Cys during the progression of periapical lesion in wild-type (WT) and toll-like receptor 2 knockout (TLR2KO) mice. Methodology.: A total of 130 C57BL/6 male WT and TLR2KO mice were allocated into control (n = 5) and experimental (periapical lesion induction) (n = 10) groups. In specific groups (WT+Pam3cys and TLR2KO+Pam3cys), the synthetic ligand Pam3cys was administered intraperitoneally every 7 days, according to the experimental period (14, 21 and 42 days). At the end of those periods, the animals were euthanized, and the mandible and the spleen were submitted to histotechnical processing. Mandible histological sections were analysed by haematoxylin and eosin, TRAP histoenzymology and immunohistochemistry (FOXP3, RANK, RANKL and OPG). Spleen sections were analysed by immunohistochemistry (FOXP3). Results: The inflammatory infiltrate and bone resorption were more intense in the TLR2KO group compared to the WT group. The animals that received the Pam3cys had smaller periapical lesions when compared to the animals that did not receive the ligand (p <.05). TLR2KO animals showed a significant increase in the number of osteoclasts when compared to TLR2KO+Pam3cys group (p <.05). At 21 days, the WT+Pam3cys group had a lower number of osteoclasts when compared to the WT animals (p =.02). FOXP3 expression was more intense in the WT+Pam3cys groups when compared to the WT animals in the 42 days (p =.03). In the spleen analysis, the WT+Pam3cys group also had a higher expression of FOXP3 when compared to the WT animals at 14 and 42 days (p =.02). Concerning RANKL, there was a reduction in staining in the KOTLR2+Pam3cys groups at 21 and 42 days (p =.03) and a higher binding ratio between RANK/RANKL in animals that did not receive the ligand. Conclusion: Administration of the Pam3cys increased the proliferation of Tregs, showed by FOXP3 expression and prevented the progression of the periapical lesion in WT mice. On the other hand, in the TLR2KO animals, Treg expression was lower with larger areas of periapical lesions. Finally, systemic administration of the Pam3cys in KO animals was able to limit the deleterious effects of the absence of the TLR2 receptor.
AB - Aim: To evaluate the role of regulatory T lymphocytes (Tregs) in the presence or absence of the synthetic ligand Pam3Cys during the progression of periapical lesion in wild-type (WT) and toll-like receptor 2 knockout (TLR2KO) mice. Methodology.: A total of 130 C57BL/6 male WT and TLR2KO mice were allocated into control (n = 5) and experimental (periapical lesion induction) (n = 10) groups. In specific groups (WT+Pam3cys and TLR2KO+Pam3cys), the synthetic ligand Pam3cys was administered intraperitoneally every 7 days, according to the experimental period (14, 21 and 42 days). At the end of those periods, the animals were euthanized, and the mandible and the spleen were submitted to histotechnical processing. Mandible histological sections were analysed by haematoxylin and eosin, TRAP histoenzymology and immunohistochemistry (FOXP3, RANK, RANKL and OPG). Spleen sections were analysed by immunohistochemistry (FOXP3). Results: The inflammatory infiltrate and bone resorption were more intense in the TLR2KO group compared to the WT group. The animals that received the Pam3cys had smaller periapical lesions when compared to the animals that did not receive the ligand (p <.05). TLR2KO animals showed a significant increase in the number of osteoclasts when compared to TLR2KO+Pam3cys group (p <.05). At 21 days, the WT+Pam3cys group had a lower number of osteoclasts when compared to the WT animals (p =.02). FOXP3 expression was more intense in the WT+Pam3cys groups when compared to the WT animals in the 42 days (p =.03). In the spleen analysis, the WT+Pam3cys group also had a higher expression of FOXP3 when compared to the WT animals at 14 and 42 days (p =.02). Concerning RANKL, there was a reduction in staining in the KOTLR2+Pam3cys groups at 21 and 42 days (p =.03) and a higher binding ratio between RANK/RANKL in animals that did not receive the ligand. Conclusion: Administration of the Pam3cys increased the proliferation of Tregs, showed by FOXP3 expression and prevented the progression of the periapical lesion in WT mice. On the other hand, in the TLR2KO animals, Treg expression was lower with larger areas of periapical lesions. Finally, systemic administration of the Pam3cys in KO animals was able to limit the deleterious effects of the absence of the TLR2 receptor.
KW - Pam3cys
KW - Tregs
KW - animal model
KW - osteoclasts
KW - periapical lesion
UR - http://www.scopus.com/inward/record.url?scp=85182704474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85182704474&partnerID=8YFLogxK
U2 - 10.1111/iej.14015
DO - 10.1111/iej.14015
M3 - Article
C2 - 38236318
AN - SCOPUS:85182704474
SN - 0143-2885
VL - 57
SP - 328
EP - 343
JO - International Endodontic Journal
JF - International Endodontic Journal
IS - 3
ER -